200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 100-64-1

100-64-1

100-64-1 | Cyclohexanone, oxime

CAS No: 100-64-1 Catalog No: AG000072 MDL No:MFCD00001660

Product Description

Catalog Number:
AG000072
Chemical Name:
Cyclohexanone, oxime
CAS Number:
100-64-1
Molecular Formula:
C6H11NO
Molecular Weight:
113.1576
MDL Number:
MFCD00001660
IUPAC Name:
N-cyclohexylidenehydroxylamine
InChI:
InChI=1S/C6H11NO/c8-7-6-4-2-1-3-5-6/h8H,1-5H2
InChI Key:
VEZUQRBDRNJBJY-UHFFFAOYSA-N
SMILES:
ON=C1CCCCC1
EC Number:
202-874-0
UNII:
2U60L00CGF
NSC Number:
6300
UN Number:
2811

Properties

Complexity:
90.7  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
113.084g/mol
Formal Charge:
0
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
113.16g/mol
Monoisotopic Mass:
113.084g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
32.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.2  

Literature

Title Journal
Spectroscopic (infrared, Raman, UV and NMR) analysis, Gaussian hybrid computational investigation (MEP maps/HOMO and LUMO) on cyclohexanone oxime. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121001
Reusable task-specific ionic liquids for a clean ε-caprolactam synthesis under mild conditions. ChemSusChem 20101217
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Oximes: metabolic activation and structure-allergenic activity relationships. Journal of medicinal chemistry 20080424
Hierarchically structured monolithic silicalite-1 consisting of crystallized nanoparticles and its performance in the Beckmann rearrangement of cyclohexanone oxime. Journal of the American Chemical Society 20050914
Analysis of rat bone marrow by flow cytometry following in vivo exposure to cyclohexanone oxime or daunomycin HCl. Toxicology and applied pharmacology 20021115
Anomalous mutagenicity profile of cyclohexanone oxime in bacteria: cell survival in background lawns. Mutation research 20011018

© 2019 Angene International Limited. All rights Reserved.